✦ LIBER ✦

Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results

✍ Scribed by Steven B. Feinstein; Jorge Cheirif; Folkert J. Ten Cate; Paul R. Silverman; Paul A. Heidenreich; Candace Dick; Ranley M. Desir; William F. Armstrong; Miguel A. Quinones; Pravin M. Shah

Book ID: 118413999
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 592 KB
Volume: 16
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(90)90580-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of a new transpulmon

Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients

✍ Bernard Geny; Bertrand Mettauer; Berit Muan; Pierre Bischoff; Eric Epailly; Fran 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 580 KB

Safety and Efficacy of Commercially Avai

Safety and Efficacy of Commercially Available Ultrasound Contrast Agents for Rest and Stress Echocardiography: A Multicenter Experience

✍ Melda S. Dolan; Simil S. Gala; Saritha Dodla; Sahar S. Abdelmoneim; Feng Xie; Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 259 KB

CaRES (Contrast Echocardiography Registr

CaRES (Contrast Echocardiography Registry for Safety Surveillance): A Prospective Multicenter Study to Evaluate the Safety of the Ultrasound Contrast Agent Definity in Clinical Practice

✍ Weiss, Robert J.; Ahmad, Masood; Villanueva, Flordeliza; Schmitz, Stephen; Bhat, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Safety and efficacy of a novel hepatobil

Safety and efficacy of a novel hepatobiliary MR contrast agent, Gd-DTPA-DeA: Results of phase I and phase II clinical trials

✍ Akihiro Tanimoto; Masumi Kadoya; Yasutaka Kawamura; Ryohei Kuwatsuru; Takehiko G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

## Abstract ## Purpose To assess the safety, effective dose, and efficacy of a novel hepatobiliary MR contrast agent Gd‐DTPA‐DeA for imaging liver tumors, from the clinical phase I and phase II trials in Japan. ## Materials and Methods In a phase I trial, 33 healthy volunteers were intravenously

A new liposomal liver-specific contrast

A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety

✍ P. Leander; Peter Höglund; Arve Børseth; Yngvil Kloster; Arne Berg 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 133 KB

Multi-centre clinical study evaluating t

Multi-centre clinical study evaluating the efficacy of SonoVue™ (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions

✍ E Leen; W.J Angerson; S Yarmenitis; G Bongartz; M Blomley; A Del Maschio; V Summ 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB